Solas BioVentures
Overview
Solas BioVentures is a venture capital firm that invests exclusively in the life sciences industry, focusing on early-stage biopharmaceuticals, medical devices, digital health technologies, and related opportunities in medicine. The firm maintains a founder-centric approach to enable breakthrough medicine and technology innovation, aiming to positively transform the standard of care and patient outcomes.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Francis Medical | Jan 2025 | Series C | Lead |
| Ischemia Care | Dec 2018 | VC Round | Co-investor |
| NX Prenatal Inc. | Aug 2023 | Series A | Lead |
| Pathware | Apr 2022 | Series A | Co-investor |
| CardioNXT, Inc. | Jun 2017 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
C David Adair
Managing Partner Co-Founder
Mark Hackett
Managing Partner And Co-Founder
Michael Hoey
General Partner
Terry Adams
General Partner
Michael Ackermann
Managing Director
MBA FFPM FRCP Laurent Pacheco
Investor & Venture Partner
MBA FFPM GFMD Laurent Pacheco
Investor Venture Partner
Lana B. Caron
Partner
A. Travis Manasco
Principal
Joshua Eckelberry
Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Solas BioVentures based?
Solas BioVentures is headquartered in Chattanooga, Tennessee, United States.
When was Solas BioVentures founded?
Solas BioVentures was founded in 2014.
How many portfolio companies does Solas BioVentures have?
Solas BioVentures has 20 portfolio companies in Caplight's dataset.
What are some companies in Solas BioVentures's portfolio?
Portfolio companies visible on Caplight include Francis Medical, Ischemia Care, NX Prenatal Inc., Pathware, CardioNXT, Inc..
What was Solas BioVentures's most recent investment shown here?
Solas BioVentures's most recent investment in this portfolio sample was in Francis Medical in 2025.
What sectors does Solas BioVentures focus on?
Solas BioVentures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Solas BioVentures focus on?
Solas BioVentures typically invests at the Mid stage.
What is Solas BioVentures's AUM?
Solas BioVentures's assets under management are estimated between $50.0M and $100.0M.